title: Quality of life predicts one-year survival in patients with implantable cardioverter defibrillators.
abstract: OBJECTIVE
  This study examines the contributions of known predictors of survival and quality of life (QOL) to 1-year survival in ICD recipients.
  
  
  METHODS
  This study used the data set from the antiarrhythmia versus implanted defibrillator (AVID) controlled clinical trial conducted by the National Institutes of Health, National Heart, Lung, and Blood Institute. The 507 patients randomly assigned to the ICD treatment were included in the analysis. Patients were mostly male (78.3%), with mean age of 64.85 +/- 10.81 and mean left ventricular ejection fraction of 32.2 +/- 13.45%. QOL was measured with the medical outcomes study 36-item short form health survey (SF-36) and quality of life index-cardiac version (QLI-CV). Data were analyzed with descriptive statistics and logistic regression.
  
  
  RESULTS
  Fifty-four (10.6%) patients died in the first year after ICD implantation. Angiotensin-converting enzyme inhibitor (ACE) medication, age, and QLI-CV were significant independent predictors of 1-year survival. The odds of survival of a younger patient with ACE medication and good QOL were approximately three times (OR = 3.96) greater than for an older patient, without ACE medication and with poor QOL.
  
  
  CONCLUSIONS
  Quality of life is an important factor predicting 1-year survival in patients with ICDs. ACE medication and younger age also predict 1-year survival independent of QOL and each other.
authors.affiliation: National Defense Medical Center School of Nursing, Taipei, Taiwan.
authors.forename: Chi-Wen
authors.initials: CW
authors.lastname: Kao
authors.forename: Erika
authors.initials: E
authors.lastname: Friedmann
authors.forename: Sue A
authors.initials: SA
authors.lastname: Thomas
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000401:mortality* / Q000628:therapy*; D017147:Defibrillators, Implantable; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D018434:Sickness Impact Profile; D016019:Survival Analysis
chemical_list: D000889:Anti-Arrhythmia Agents